Home > Insider Trading > Filing (0001179110-21-005974)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1551306	Progyny Inc.	PGNY	Services-Misc Health & Allied Services, Nec (8090)	272220139

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1789513	Jennifer Bealer	C/O Progyny, Inc. 1359 Broadway, 2Nd Fl New York NY 10018	Evp, General Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-05-24	633	$3.95	86,989	No	4	M	Direct
Common Stock	Disposition	2021-05-24	333	$57.79	86,656	No	4	F	Direct
Common Stock	Disposition	2021-05-24	300	$57.86	86,356	No	4	S	Direct
Common Stock	Acquisiton	2021-05-24	3,438	$3.95	89,794	No	4	M	Direct
Common Stock	Disposition	2021-05-24	1,804	$57.79	87,990	No	4	F	Direct
Common Stock	Disposition	2021-05-24	1,634	$57.78	86,356	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Disposition	2021-05-24	633	$0.00	633	$3.95
Common Stock	Employee Stock Option (right to buy)	Disposition	2021-05-24	3,438	$0.00	3,438	$3.95

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
13,915		2029-05-21	No	4	M	Direct
82,501		2029-05-23	No	4	M	Direct

Footnotes

Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 18, 2020.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.78 to $57.79 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
One-fourth (1/4th) of the shares subject to the Option vested on March 20, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
One-fourth (1/4th) of the shares subject to the Option vested on May 23, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.